Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Predicting survival in mesothelioma

Arthur William Musk
European Respiratory Journal 2012 40: 1582; DOI: 10.1183/09031936.00102612
Arthur William Musk
*Dept of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands
#Medicine and Population Health, University of Western Australia, Crawley, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Bill.Musk@health.wa.gov.au
  • Article
  • Info & Metrics
  • PDF
Loading

From the author:

Thank you for the opportunity to respond to the thoughtful letter from J.G. Smith [1].

The main issues she raises stem from the original paper having aims other than use for prediction in current individual or legal cases. Our main aim was to describe the epidemiology of malignant mesothelioma in Western Australia and to demonstrate how little improvement there has been in survival over the last 30 yrs, despite large changes in treatment [2]. Thus, we fitted survival models to all available data. The complicated age terms were just the best-fitting fractional polynomial fit to these data. Further analyses revealed that the u-shaped survival with age was caused by the comparatively poor survival in patients diagnosed under the age of 40 yrs, such that when these were excluded from analysis, a linear decline in age was the best fit. We also included all patients with an unknown site of mesothelioma, leading to the apparently anomalous better survival in this group.

We suggest that if a survival model is to be developed and used for individual prediction (possibly in legal cases), we would need to exclude: patients who were diagnosed at death; possibly all those with unrecorded histology; all those with unspecified site of disease; and possibly all those diagnosed before 1980 (or maybe 1990 or later).

To that end, we have spoken with J.G. Smith and suggested that we work together with the necessary subset of the data (which may soon include an additional year of accrued cases) in order to produce a revised publishable model that would have much greater utility in the context for which she wishes to use it.

Footnotes

  • Statement of Interest

    None declared.

  • ©ERS 2012

REFERENCES

  1. ↵
    1. Smith JG
    . Predicting survival in malignant mesothelioma. Eur Respir J 2012; 40: 799.
    OpenUrlFREE Full Text
  2. ↵
    1. Musk AW,
    2. Olsen N,
    3. Alfonso H,
    4. et al
    . Predicting survival in malignant mesothelioma. Eur Respir J 2011; 38: 1420–1424.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 40 Issue 6 Table of Contents
European Respiratory Journal: 40 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predicting survival in mesothelioma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Predicting survival in mesothelioma
Arthur William Musk
European Respiratory Journal Dec 2012, 40 (6) 1582; DOI: 10.1183/09031936.00102612

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Predicting survival in mesothelioma
Arthur William Musk
European Respiratory Journal Dec 2012, 40 (6) 1582; DOI: 10.1183/09031936.00102612
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Subjects

  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Endothelial to mesenchymal transition as novel feature of pulmonary fibrosis
  • Transitioning endothelial cells contribute to pulmonary fibrosis
  • Treatable traits in ILD: why not consider acute exacerbations?
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society